{
  "id": 3044097,
  "title": "Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either.",
  "url": "https://urgent.news/2026/08/24/billionaire-stanley-druckenmiller-bought-amazon-and-alphabet-in-q2-3044097",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-24T14:00:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/08/24/billionaire-stanley-druckenmiller-bought-amazon-an/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Stanley Druckenmiller, the renowned billionaire macro investor, recently disclosed his latest 13F holdings, revealing that his largest investment was not in the expected tech giants like Amazon and Alphabet, nor in the high-flying Nvidia. Instead, a substantial portion of his portfolio was allocated to a genetic testing company named Natera (NASDAQ: NTRA), representing nearly one-fifth of his investments. This unusual choice has caught the attention of observers, prompting them to question the reasoning behind Druckenmiller's decision to stake such a significant portion of his wealth in a mid-cap diagnostics firm. Natera specializes in molecular diagnostics, focusing on the analysis of minute DNA fragments found in blood to provide insights into various aspects of human health, including pregnancy, cancer, and organ function.",
  "summary": "Natera's growth, expanding role in cancer care, and growing diagnostic data platform help explain why Druckenmiller has made it a major portfolio holding, despite valuation and regulatory risks.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}